Shanghai Lily&Beauty Cosmetics Co.,Ltd.

SSE:605136.SS

7.72 (CNY) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12017 Q22017 Q12016 Q1
Revenue 501.276260.781491.104469.926832.099491.23824.749614.3141,143.484540.872842.208714.9661,654.154645.051,100.383755.2672,135.918659.2491,150.755653.8751,628.824588.148976.403828.748606.577606.577273.064
Cost of Revenue 326.654150.753313.254322.23484.487344.187579.754399.114872.416404.761624.903462.4121,205.173350.577651.238433.2121,443.519391.438725.281388.2091,070.809375.113621.417532.102390.362390.362162.587
Gross Profit 174.622110.027177.85147.696347.612147.044244.995215.2271.068136.111217.305252.555448.98294.473449.144322.055692.4267.811425.474265.666558.015213.034354.986296.646216.215216.215110.477
Gross Profit Ratio 0.3480.4220.3620.3140.4180.2990.2970.350.2370.2520.2580.3530.2710.4570.4080.4260.3240.4060.370.4060.3430.3620.3640.3580.3560.3560.405
Reseach & Development Expenses 5.725.9445.5996.1737.905-1.0424.2591.1482.4383.4692.9333.1620.394.82.583.2566.0042.1451.6912.0641.9342.631.8433.23000
General & Administrative Expenses -28.38359.025-1.7623.27-50.83375.773-14.81130.802-49.18885.433-19.91732.146-32.27962.832-11.6929.481-37.85524.066-7.96218.573-33.10221.51621.77219.4218.2118.2112.901
Selling & Marketing Expenses -39.334198.28152.778129.886240.257108.14184.203150.893218.178158.748195.323155.277169.165210.948258.962197.03381.408183.608286.488166.691394.952133.092249.132216.357150.897150.89785.486
SG&A -67.718257.305174.941149.151189.424183.913169.392181.694168.99244.181175.406187.423136.886273.78247.272226.511343.553207.674278.527185.264361.85154.608280.825235.768169.107169.10798.387
Other Expenses 223.195-120.4715.663-8.3866.7391.362-1.5510.01879.734-51.20714.3991.6754.319-16.66714.7750.022-0.5250.0580.005-1.05813.804-0.0160000-0.036
Operating Expenses 161.197146.115164.877163.709272.671140.037212.545182.86251.162196.443192.737192.26202.044242.37246.789228.899426.771208.17285.861182.935420.205156.629218.135205.724177.143177.14399.517
Operating Income 13.426-63.97212.973-16.013111.476-37.7541.112-30.526-111.352-60.33231.30262.117204.79368.966212.42657.519196.69953.799138.87454.526118.73359.325120.04285.04545.85445.85412.558
Operating Income Ratio 0.027-0.2450.026-0.0340.134-0.0770.001-0.05-0.097-0.1120.0370.0870.1240.1070.1930.0760.0920.0820.1210.0830.0730.1010.1230.1030.0760.0760.046
Total Other Income Expenses Net -0.08327.191-1.297-0.05-0.036-0.18-0.009-0.56-0.9920.118-41.285-0.177-1.196-0.739-1.1530.022-0.190.0580.005-1.058-0.152-0.016-0.0259.2930.7650.765-0.036
Income Before Tax 13.343-36.78118.159-11.741111.44-37.9341.103-31.086-112.345-64.662-9.98215.282203.59868.227211.27357.541196.50953.857138.87953.467118.58159.309141.09294.33848.39948.39912.521
Income Before Tax Ratio 0.027-0.1410.037-0.0250.134-0.0770.001-0.051-0.098-0.12-0.0120.0210.1230.1060.1920.0760.0920.0820.1210.0820.0730.1010.1450.1140.080.080.046
Income Tax Expense 10.434-5.946.474-1.7830.299-10.2492.623-6.387-9.958-18.155-2.9392.73454.58112.23450.73513.27347.90212.66931.71912.62127.45615.58131.23319.52410.98710.9871.619
Net Income 3.396-30.4912.24-9.54681.459-27.9870.346-24.699-102.386-46.507-7.04312.696149.2756.14160.82944.498147.85641.352107.89642.37690.66644.088110.56275.6237.67137.67110.903
Net Income Ratio 0.007-0.1170.025-0.020.098-0.0570-0.04-0.09-0.086-0.0080.0180.090.0870.1460.0590.0690.0630.0940.0650.0560.0750.1130.0910.0620.0620.04
EPS 0.009-0.0760.031-0.0240.2-0.070.001-0.062-0.26-0.11-0.0170.030.370.140.40.110.370.10.310.120.250.120.310.210.110.110.03
EPS Diluted 0.009-0.0760.031-0.0240.2-0.070.001-0.062-0.26-0.11-0.0170.030.370.140.40.110.370.10.310.120.250.120.310.210.110.110.03
EBITDA 13.584-36.42323.855-11.472117.59712.7067.233-25.087-105.045-58.63732.46321.221205.09768.693214.27557.584197.38253.894138.8953.467119.38259.309120.67585.67946.48246.48213.155
EBITDA Ratio 0.027-0.140.049-0.0240.1410.0260.009-0.041-0.092-0.1080.0390.030.1240.1060.1950.0760.0920.0820.1210.0820.0730.1010.1240.1030.0770.0770.048